Connect with us

National

Calgary company begins human clinical trials for its COVID-19 vaccine candidate – Eckville Echo

If successful, the vaccine could be released by the end of the year

Published

on

post featured image

Human clinical trials have begun in Toronto for a proposed COVID-19 vaccine made by a Canadian company.
Providence Therapeutics of Calgary says 60 subjects will be monitored for 13 months, with the first results expected next month.
The group of healthy volunteers aged 18 to 65 have been divided into four groups of 15. Three of the groups will get three different dose levels, while a fourth group gets a placebo.
Pending regulatory approval, the company’s CEO Brad Sorenson says a larger Phase 2 trial…

Click here to view the original article.